Trial Profile
A Randomized, Open-label, Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Dialysis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 23 Dec 2021
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary)
- Indications Renal failure; Secondary hyperparathyroidism
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 18 Dec 2021 This trial has been completed in Italy (End date: 2016-06-23) as per European Clinical Trials Database record.
- 28 Jul 2016 This trial was completed in Greece (end date: 2016-06-23).
- 21 Jul 2016 This trial was completed in Slovakia (end date: 23-06-2016), according to European Clinical Trials Database.